Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FQRP6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,943
Award facts
- Contract value 100% obligated
- $6,943.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $6,943.10 for Nexplanon 68 mg implants. The award, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, represents a routine pharmaceutical supply delivery under the agency's broader procurement framework. This delivery order carries no set-aside designation, indicating that DMS Pharmaceutical Group competed openly in the federal marketplace despite its woman-owned small business status. The place of performance is the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This overarching IDC framework enables the DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. The Nexplanon implants—a contraceptive device—represent a specialized pharmaceutical product within the broader portfolio of medical supplies that DMS Pharmaceutical Group delivers to military health facilities, establishing the company as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQRP6?
SPE2DB25FQRP6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FQRP6 worth?
The government has obligated $6,943 on SPE2DB25FQRP6.
Is contract SPE2DB25FQRP6 an order under another contract?
Yes. SPE2DB25FQRP6 is a delivery order under SPE2DB20D9201, an indefinite delivery contract.
Was contract SPE2DB25FQRP6 competed?
The extent of competition for SPE2DB25FQRP6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award